AROS – the company and the staff
AROS provides service to industry and universities world-wide. The service
includes sample banking, extraction of molecules, microarray analysis,
PCR-based testing, and large clinical cohort studies.
AROS develops and test new molecular diagnostic technologies both
in vitro and based on clinical materials.
AROS has:
• Academic staff (all PhD´s) with a long track record in microarray and molecular research
• Quality assurance staff trained at European level
• Technicians with many years of experience in microarray handling
• Support staff taking care of shipments, contracts, array purchase etc.
Company background
The Dept. of Clinical Biochemistry at Aarhus University Hospital purchased the first academic Affymetrix system in Europe in 1999, and quickly became a reference laboratory for Affymetrix in Europe. As service for the Pharma industry grew rapidly, it was decided to spin-out AROS as an independent company.
AROS was established as a
limited liability company in the year 2000 by three researchers from Aarhus University Hospital
, the Hospital, and a local public investment fund. At the same time, AROS moved to its own facility, expanded, and - in 2005 - had to
move to a new larger facility in a new Biomedical Research Park, located
next to the University Hospital.
AROS transformed into an incorporation in 2005 and has had a positive balance since 2002.
The management team
• Chairman of the Board: Professor Torben F. Ørntoft
• Chief Executive Officer: Brian Sørensen
• Chief Operating Officer: PhD Thomas
Thykjaer
• Chief Scientific Officer: PhD Mogens
Kruhøffer
The staff
AROS has been steadily growing and has kept
the position as the leading service provider for Affymetrix in Europe.
Up to date, AROS staff has hybridized and analysed more than 12,000 microarrays.
The staff has carefully been selected for technological skills, as well
as talent for quality assured performance. On top of that the staff is
friendly and always interacting with the customers according to their
needs.